(Q44877985)

7 December 2017

title

Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center (English)

1 reference

7 December 2017

1 reference

1 reference

1 reference

Bradley BC

1

1 reference

7 December 2017

Perdue KS

series ordinal

2

1 reference

7 December 2017

Tisdel KA

series ordinal

3

1 reference

7 December 2017

Gilligan DM

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

American Journal of Cardiology

7 December 2017

published in

1 reference

7 December 2017

volume

85

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

568-572

1 reference

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Canadian atrial fibrillation anticoaguiation (CAFA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Antithrombotic therapy in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Recent national patterns of warfarin use in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Atrial fibrillation and stroke prevention with warfarin in the long-term care setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Hemorrhagic complications of anticoagulant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Survey of use of anticoagulation in patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Population based study of use of anticoagulants among patients with atrial fibrillation in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

Use of warfarin for nonvalvular atrial fibrillation in nursing home patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900813-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(99)00813-9

1 reference

release_nwfnylzy5ve3vfxhlzrr3byfn4

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nwfnylzy5ve3vfxhlzrr3byfn4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference